XtalPi Holdings Limited (HKG:2228)

Market Cap	48.24B +189.6%
Revenue (ttm)	746.09M +245.5%
Net Income	-215.64M
EPS	-0.07
Shares Out	4.30B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,407,860
Average Volume	59,108,387
Open	11.16
Previous Close	11.16
Day's Range	11.04 - 11.29
52-Week Range	3.85 - 15.12
Beta	n/a
RSI	42.97
Earnings Date	Mar 30, 2026

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicoch...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 1,054
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.

Financial numbers in CNY